Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: In the last letter to the shareholders

In the last letter to the shareholders

posted on Apr 07, 2008 07:20AM
RG stated that change is both inevitable and disconcerting. He also told us that there are certain disclosures that he could not make at this time and his sign off was "until next month"--I expect that we will be hearing from RG within the next two days. GL, ads
Share
New Message
Please login to post a reply